ALBAlbemarle Corporation

$101.29+26% 1Y

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +18% year on year and operating margin widening (+21.6 points), but earnings down −103% year on year.

2 good, 1 to watch
Revenue trend+18% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +13% a year.

Earnings trend−103% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction+21.6 points operating

Trailing-twelve-month operating margin, 2.6% now against -19.0% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbottom 1% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is ALB growing?

Albemarle Corporation has grown revenue −15% a year over three years and 13% a year over five, with earnings per share compounding at −80%.

−15%

Revenue growth, 3-year annual rate · Specialty Chemicals median +3.3% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate
+13%

Revenue growth, 5-year rate · −15% over three · growth has slowed since the five-year average

Earnings per share, 3-year rate
−80%

Earnings per share, 3-year rate · revenue −15% · earnings lagged revenue: the growth is costing something

Years of annual history on file
18

Years of annual history on file · FY2008 to FY2025, as filed

Details›
Revenue FY2021
$3.33B
Revenue FY2022
$7.32B
Revenue FY2023
$9.62B
Revenue FY2024
$5.38B
Revenue FY2025
$5.14B

Annual income statements as filed with the SEC.